Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Protumor effects of proinflammatory mediators in breast cancer (CROSBI ID 191449)

Prilog u časopisu | pregledni rad (znanstveni) | međunarodna recenzija

Sirotković-Skerlev, Maja ; Kulić, Ana ; Bradić, Lada ; Čačev, Tamara Protumor effects of proinflammatory mediators in breast cancer // Periodicum biologorum, 114 (2012), 4; 489-496

Podaci o odgovornosti

Sirotković-Skerlev, Maja ; Kulić, Ana ; Bradić, Lada ; Čačev, Tamara

engleski

Protumor effects of proinflammatory mediators in breast cancer

Inflammation is defined as an enabling characteristic of malignant growth. Many proinflammatory mediators have protumor capabilities. In this review we focus on the protumor effect of cytokines and chemokines in breast cancer. We discuss the role of interleukin 1β, interleukin 6, tumor necrosis factor α, CCL2, CCL5, and CXCL12 and its receptor CXCR4 as typical mediators implicated in breast cancer progression. We also analyze the impact of transcription factor NF-κB. Proinflammatory mediators with protumor effects should be considered as therapeutic targets in breast cancer. It is challenging how to find optimal anti-cytokine and anti-chemokine regiments as a part of anticancer therapy.

breast cancer ; cytokines ; chemokines

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

114 (4)

2012.

489-496

objavljeno

0031-5362

Povezanost rada

Temeljne medicinske znanosti

Poveznice
Indeksiranost